Medpace Holdings, Inc. (MEDP) Dividend History

Company News

• Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - Trends, Opportunities, and Forecasts 2020-2030

  The global regulatory affairs outsourcing market is expected to grow significantly from 2024 to 2030, driven by the globalization of biopharmaceutical and medical device companies and the need for specialized regulatory expertise. Technological advancements in regulatory processes are also shaping the market.

  GlobeNewswire Inc.

  Featured Companies: CRL G ICLR
• MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

  Medpace Holdings, Inc. reported a lower-than-expected net book-to-bill ratio in Q3 2024, leading to a 7% drop in its stock price. The law firm Kessler Topaz Meltzer & Check is investigating potential securities law violations on behalf of Medpace investors.

  GlobeNewswire Inc.
• Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws

  Wolf Haldenstein Adler Freeman & Herz LLP is investigating Medpace Holdings, Inc. for potential securities law violations after Jefferies Financial Group Inc. downgraded the company, citing perceived weaknesses in its business model.

  GlobeNewswire Inc.

  Featured Companies: JEF
• MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm

  Medpace Holdings, Inc. reported a lower-than-expected net book-to-bill ratio for the third quarter, leading to a drop in its stock price. The law firm Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Medpace investors.

  GlobeNewswire Inc.
• NASDAQ: MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

  Medpace Holdings, Inc. (NASDAQ: MEDP) reported lower-than-expected financial results and a decline in its net book-to-bill ratio, a key indicator of demand, leading to a significant drop in its stock price.

  GlobeNewswire Inc.